{"id":18217,"date":"2019-05-17T23:06:06","date_gmt":"2019-05-17T23:06:06","guid":{"rendered":"http:\/\/thepatientinvestor.com\/?p=18217"},"modified":"2019-05-18T00:01:10","modified_gmt":"2019-05-18T00:01:10","slug":"is-the-sp-500-way-over-priced","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/","title":{"rendered":"Is the S&#038;P 500 way over-priced?"},"content":{"rendered":"<p>Robert Shiller&#8217;s CAPE (Price\/10-year simple MA of inflation-adjusted earnings) is at 30.31, the second-highest peak (behind the Dotcom bubble) in 120 years.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png?w=525&#038;ssl=1\" alt=\"S&amp;P 500 CAPE\" \/><\/p>\n<p>PEmax (Price\/highest prior 12-month earnings) is far lower at 21.04. I prefer this as a more accurate measure of stock pricing than CAPE. But PEmax is still high relative to the peaks of <em>Black Friday<\/em> in October 1929 and <em>Black Monday<\/em> in October 1987.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-pemax.png?w=525&#038;ssl=1\" alt=\"S&amp;P 500 PE of Maximum Prior Earnings\" \/><\/p>\n<p>Forecast earnings for the remainder of 2019 may be slightly optimistic, given recent escalation of the US-China trade war, but the forward price-earnings multiple is lower, at 18.62. The sharp difference between forward and historic PE ratios (as in PEmax) is largely attributable to the earnings hiccup in Q4 of 2018 which is excluded from the forward ratio.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2019-05-13-fpe.png?w=525&#038;ssl=1\" alt=\"S&amp;P 500 Forward Price-Earnings Ratio\" \/><\/p>\n<p>Forecast earnings growth, on the chart below, shows a similar anomaly in Q4 of the current year, caused by comparison to the earnings dip in Q4 of 2018. Forecasts assume that earnings will grow between 7.1% and 7.8% for the rest of 2019, rising to above 11% in 2020.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-eps-growth.png?w=525&#038;ssl=1\" alt=\"S&amp;P 500 Earnings Growth\" \/><\/p>\n<p>Their projections seem optimistic.<\/p>\n<p>Year-on-year sales growth is a modest 5.8% for Q1 of 2019 and is likely to continue between 4.0% and 6.0% for the foreseeable future. The spike in sales growth in 2017 &#8211; 2018 is a result of recovery from negative growth in 2015 and is unlikely to be repeated.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-sales-qtr.png?w=525&#038;ssl=1\" alt=\"S&amp;P 500 Quarterly Sales\" \/><\/p>\n<p>Operating margins are just as important. Margins recovered to 11.25% for Q1 2019 (89.9% of stocks reported), after a sharp fall in Q4 2018, but it is questionable whether these are sustainable.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-margins.png?w=525&#038;ssl=1\" alt=\"S&amp;P 500 Quarterly Operating Margins\" \/><\/p>\n<h2>Conclusion<\/h2>\n<p>Earnings forecasts seem optimistic. With lower sales growth and downside risk in operating margins, long-term earnings growth of between 4.0% and 6.0% is likely. The 30-year average is 6.17% p.a. but low inflation (and a possible trade war) is likely to see us undershoot this.<\/p>\n<p>Forward Price-Earnings ratio of 18.6 is on the high side for expected low earnings growth. A forward PE of 16.0 or less, however, should be viewed as a buy opportunity.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Robert Shiller&#8217;s CAPE (Price\/10-year simple MA of inflation-adjusted earnings) is at 30.31, the second-highest peak (behind the Dotcom bubble) in 120 years. PEmax (Price\/highest prior 12-month earnings) is far lower at 21.04. I prefer this as a more accurate measure of stock pricing than CAPE. But PEmax is still high relative to the peaks of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Is the S&#038;P 500 way over-priced?&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[57,34],"tags":[567,4045,4046,3766,4047],"class_list":["post-18217","post","type-post","status-publish","format-standard","hentry","category-stock-markets","category-us-canada-countries-regions","tag-cape","tag-forward-pe","tag-operating-margins","tag-pemax","tag-sales-growth"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Is the S&amp;P 500 way over-priced? - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is the S&amp;P 500 way over-priced? - the patient investor\" \/>\n<meta property=\"og:description\" content=\"Robert Shiller&#8217;s CAPE (Price\/10-year simple MA of inflation-adjusted earnings) is at 30.31, the second-highest peak (behind the Dotcom bubble) in 120 years. PEmax (Price\/highest prior 12-month earnings) is far lower at 21.04. I prefer this as a more accurate measure of stock pricing than CAPE. But PEmax is still high relative to the peaks of &hellip; Continue reading &quot;Is the S&#038;P 500 way over-priced?&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-17T23:06:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-18T00:01:10+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Is the S&#038;P 500 way over-priced?\",\"datePublished\":\"2019-05-17T23:06:06+00:00\",\"dateModified\":\"2019-05-18T00:01:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/\"},\"wordCount\":313,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png\",\"keywords\":[\"CAPE\",\"Forward PE\",\"Operating Margins\",\"PEMAX\",\"Sales Growth\"],\"articleSection\":[\"Stock Markets\",\"US &amp; Canada\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/\",\"name\":\"Is the S&P 500 way over-priced? - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png\",\"datePublished\":\"2019-05-17T23:06:06+00:00\",\"dateModified\":\"2019-05-18T00:01:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Is the S&#038;P 500 way over-priced?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\",\"https:\/\/au.linkedin.com\/in\/colintwiggs\"],\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is the S&P 500 way over-priced? - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Is the S&P 500 way over-priced? - the patient investor","og_description":"Robert Shiller&#8217;s CAPE (Price\/10-year simple MA of inflation-adjusted earnings) is at 30.31, the second-highest peak (behind the Dotcom bubble) in 120 years. PEmax (Price\/highest prior 12-month earnings) is far lower at 21.04. I prefer this as a more accurate measure of stock pricing than CAPE. But PEmax is still high relative to the peaks of &hellip; Continue reading \"Is the S&#038;P 500 way over-priced?\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2019-05-17T23:06:06+00:00","article_modified_time":"2019-05-18T00:01:10+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Is the S&#038;P 500 way over-priced?","datePublished":"2019-05-17T23:06:06+00:00","dateModified":"2019-05-18T00:01:10+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/"},"wordCount":313,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png","keywords":["CAPE","Forward PE","Operating Margins","PEMAX","Sales Growth"],"articleSection":["Stock Markets","US &amp; Canada"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/","name":"Is the S&P 500 way over-priced? - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png","datePublished":"2019-05-17T23:06:06+00:00","dateModified":"2019-05-18T00:01:10+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2018\/2019-05-13-spx-cape.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2019\/05\/17\/is-the-sp-500-way-over-priced\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Is the S&#038;P 500 way over-priced?"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-4JP","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":17741,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/01\/15\/pemax-why-you-should-be-cautious-using-robert-shillers-cape\/","url_meta":{"origin":18217,"position":0},"title":"PEmax and why you should be wary of Robert Shiller&#8217;s CAPE","author":"Colin Twiggs","date":"January 15, 2019","format":false,"excerpt":"Robert Shiller's groundbreaking works, Irrational Exuberance and Animal Spirits, led to a Nobel prize in 2013 but we need to be careful of placing too much reliance on his CAPE as an indicator of stock market value. What is CAPE? CAPE is the cyclically adjusted price-to-earnings ratio, normally applied to\u2026","rel":"","context":"In &quot;Earnings &amp; Dividends&quot;","block_context":{"text":"Earnings &amp; Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16039,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/12\/09\/cape-v-pemax-how-hot-are-market-valuations\/","url_meta":{"origin":18217,"position":1},"title":"CAPE v PEMAX: How hot are market valuations?","author":"Colin Twiggs","date":"December 9, 2017","format":false,"excerpt":"Robert Shiller's CAPE ratio is currently at 32.17, the second-highest peak in recorded history. According to multpl.com, prior to the Black Tuesday crash of 1929 CAPE had a reading of 30. The only peak with a higher reading is the Dotcom bubble at 44. Click here to view at multpl.com.\u2026","rel":"","context":"In &quot;Quotes&quot;","block_context":{"text":"Quotes","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/quotes\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":21187,"url":"https:\/\/thepatientinvestor.com\/index.php\/2020\/08\/07\/sp-500-pemax-at-24\/","url_meta":{"origin":18217,"position":2},"title":"S&#038;P 500 PEmax at 24","author":"Colin Twiggs","date":"August 7, 2020","format":false,"excerpt":"The S&P 500 is way over-priced based on all three earnings multiples. 75% of companies in the S&P 500 have already reported earnings, so we have a good idea as to what overall earnings will be for the second quarter. Based on the latest index price of 3349.16, trailing PE\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16054,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/12\/17\/pemax-second-highest-peak-in-last-100-years\/","url_meta":{"origin":18217,"position":3},"title":"PEMAX second highest peak in 100 years","author":"Colin Twiggs","date":"December 17, 2017","format":false,"excerpt":"I published a chart of PEMAX for the last 30 years on Saturday. PEMAX eliminates the distortion caused by cyclical earnings fluctuations, using the highest earnings to-date rather than current earnings. The idea being that cyclical declines in earnings reflect a fall in capacity utilization rather than a long-term drop\u2026","rel":"","context":"In &quot;Earnings &amp; Dividends&quot;","block_context":{"text":"Earnings &amp; Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":26535,"url":"https:\/\/thepatientinvestor.com\/index.php\/2021\/06\/26\/sp-500-and-the-fed-taper\/","url_meta":{"origin":18217,"position":4},"title":"S&#038;P 500 and the Fed taper","author":"Colin Twiggs","date":"June 26, 2021","format":false,"excerpt":"S&P 500 earnings forecasts show a sizable jump in the March quarter (97.3% reported) followed by a weaker June quarter as the economy struggles with supply chain interruptions and labor shortages. Record operating margins of 13.0% estimated for the first quarter (March '21) are unlikely to be repeated. The average\u2026","rel":"","context":"In &quot;GDP and Activity&quot;","block_context":{"text":"GDP and Activity","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/gdp-and-activity\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16299,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/","url_meta":{"origin":18217,"position":5},"title":"Price &#038; Earnings: The Race to the Top","author":"Colin Twiggs","date":"May 23, 2018","format":false,"excerpt":"Now that 93% of S&P 500 stocks have reported first quarter earnings we can look at price-earnings valuation with a fair degree of confidence. My favorite is what I call PEMax, which compares Price to Maximum Annual Earnings for current and past years. This removes distortions caused by periods when\u2026","rel":"","context":"In &quot;Earnings &amp; Dividends&quot;","block_context":{"text":"Earnings &amp; Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/18217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=18217"}],"version-history":[{"count":10,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/18217\/revisions"}],"predecessor-version":[{"id":18234,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/18217\/revisions\/18234"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=18217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=18217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=18217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}